UBS Group
DRTSW icon

UBS Group’s Alpha Tau Medical Warrant DRTSW Stock Holding History

UBS Group’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,360
Closed -$7.26K – 10639
2025
Q4 		$7.26K Sell
21,360
-4,260
-17% -$1.44K ﹤0.01% 8461
2025
Q3 		$8.84K Sell
25,620
-2,769
-10% -$786 ﹤0.01% 8635
2025
Q2 		$6.25K Buy
28,389
+17,813
+168% +$3.96K ﹤0.01% 9108
2025
Q1 		$2.52K Buy
10,576
+8,093
+326% +$2.41K ﹤0.01% 9315
2024
Q4 		$521 Sell
2,483
-317
-11% -$65 ﹤0.01% 9437
2024
Q3 		$532 Buy
2,800
+369
+15% +$76 ﹤0.01% 8907
2024
Q2 		$493 Buy
2,431
+2,290
+1,624% +$543 ﹤0.01% 8901
2024
Q1 		$35 Buy
+141
New +$37 ﹤0.01% 8966

Other funds holding DRTSW

FFM
Fisher Funds Management Auckland, New Zealand $3.41B AUM 11.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return
MCM
Moore Capital Management New York $2.75B AUM 35.41% 1-Year Est. Return
VB
Value Base Tel Aviv, Israel $127M AUM 12.37% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $6.95B AUM 15.85% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return
ICM
Ionic Capital Management New York $119M AUM 48.26% 1-Year Est. Return